Home » Newsletters » BioWorld Science

BioWorld Science

July 1, 2002

View Archived Issues

L.A.M. IPM Wound Gel to be launched in August 2002

Purification process for amediplase successfully developed through collaboration

Forbes Medi-Tech reaches agreement with Novartis for rights to Reducol

NDA filing completed for oxaliplatin in advanced colorectal cancer

Xyotax demonstrates ability to control disease in chemotherapy-resistant cancer patients

Genesis Bioventures and Corgenix to develop breast cancer risk diagnostic test

Aphidicolin derivatives active against HSV-1 and HCMV

Small-molecule cathepsin K inhibitor prevents bone resorption and bone loss in rat model

AM-336 may be preferable to ziconotide for the treatment of chronic pain

Orally active adenosine kinase inhibitor A-286501 effective in rat models of pain

Novel VLA-4 antagonists in Aventis Pharma patent

New angiogenesis inhibitors in Boehringer Ingelheim pipeline

Cyclodextrins with cortisol-sequestering activity and their use

F2G and Genome Therapeutics collaborate in antifungal drug discovery

New antiarrhythmic K(ATP) channel blockers claimed by Aventis Pharma

Antitumor compounds with affinity for Hsp90

5-HT6 receptor modulators in early development at Wyeth

Chugai shareholders vote in favor of Roche alliance

5-HT7 antagonists and their use in pain, schizophrenia, etc.

AtheroGenics to advance AGI-1067 in atherosclerosis

E.U. approval of irbesartan for renal disease in hypertensive and type 2 diabetes patients

SMART anti-IL-12 antibody enters phase I

MorphoSys antibodies reach Alzheimer's target in Roche collaboration

Long-term results for Photofrin show potential efficacy in prevention of esophageal cancer

Questcor licenses worldwide rights to Hypnostat and Panistat to Fabre Kramer

IND filed for ALS-886

Incara submits IND for liver cell transplantation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...